Last Updated: August 25, 2026

CLINICAL TRIALS PROFILE FOR AVACOPAN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for avacopan

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02994927 ↗	A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis	Completed	ChemoCentryx	Phase 3	2017-03-15	The aim of the trial is to assess the safety and efficacy of the orally-administered, selective complement C5a receptor inhibitor CCX168 (avacopan) in inducing and sustaining remission in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
NCT03301467 ↗	Controlled Trial Evaluating Avacopan in C3 Glomerulopathy	Active, not recruiting	Medpace, Inc.	Phase 2	2017-09-29	The aim of this trial is to evaluate the effect of avacopan treatment on renal disease activity in patients with complement component 3 glomerulopathy (C3G). Funding Source - FDA OOPD
NCT03301467 ↗	Controlled Trial Evaluating Avacopan in C3 Glomerulopathy	Active, not recruiting	ChemoCentryx	Phase 2	2017-09-29	The aim of this trial is to evaluate the effect of avacopan treatment on renal disease activity in patients with complement component 3 glomerulopathy (C3G). Funding Source - FDA OOPD
NCT03852472 ↗	Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)	Active, not recruiting	ChemoCentryx	Phase 2	2018-12-28	Phase 2 study of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for avacopan

Condition Name

Chart
Table

Condition Name for avacopan
Intervention	Trials
Granulomatosis With Polyangiitis	2
Healthy Volunteers	1
Hidradenitis Suppurativa	1
IgA Nephropathy (IgAN)	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for avacopan
Intervention	Trials
Vasculitis	4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	4
Granulomatosis with Polyangiitis	3
Microscopic Polyangiitis	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for avacopan

Trials by Country

Map
Table

Trials by Country for avacopan
Location	Trials
United States	92
Japan	14
Canada	6
Spain	4
France	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for avacopan
Location	Trials
New York	6
Pennsylvania	5
Ohio	5
Minnesota	5
Indiana	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for avacopan

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for avacopan
Clinical Trial Phase	Trials
PHASE4	1
PHASE3	2
PHASE2	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for avacopan
Clinical Trial Phase	Trials
RECRUITING	4
Completed	3
Active, not recruiting	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for avacopan

Sponsor Name

Chart
Table

Sponsor Name for avacopan
Sponsor	Trials
Amgen	5
ChemoCentryx	3
Ottawa Hospital Research Institute	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for avacopan
Sponsor	Trials
Industry	10
OTHER	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.